From§Each

SATURDAY, 17 OCTOBER 2026 — THE AFTERNOON EDITION

Health

Page H1

ONE DETECTIVE

CDC meets six measles deaths in Pennsylvania with one disease detective.

Pennsylvania at the center of US measles outbreaks (Photo via The Hill)

Measles elimination, certified by the United States government in the year 2000, is dead in Pennsylvania. It was twenty-six years old. The cause, by the state's own count, is six.

It was already failing by October 4, when officials in Harrisburg said it was "only a matter of time" before the disease spread past its epicenter — a county that, like most in the Commonwealth, has no health department of its own — citing a fifth death already confirmed among 943 cases across 39 counties. The next day the case count passed 1,000 outright, the largest outbreak Pennsylvania has recorded in more than three decades; the same dispatch noted that New York had declared its own state of emergency about measles rates there. On Friday, October 9, Pennsylvania recorded its sixth death.

By Wednesday the count stood at 1,222 cases, up from the 1,004 confirmed twelve days before. The county at the center of it still has no health department of its own. What it has, as of this week, is one person: a single Centers for Disease Control and Prevention "disease detective," a penny-ante dispatch to a county four months into an outbreak that has already produced six funerals.

It is survived by 1,222 confirmed cases and climbing, by the thirty-nine counties the state was already worried about on October 4, and by six families who were told, in the year 2000, that this particular grief had been retired. It is preceded in death by the county health department it never had; most of the state's counties don't, officials said on October 4, one day before the case count crossed into quadruple digits.

The elimination notice stood for a quarter century on the plain premise that an eliminated disease stays eliminated — not through vigilance that makes the news, but through the structure underneath it. The structure is not there. One detective, sent in October to a county with no department to detect anything, is not a replacement for it. One detective is a sympathy card.

In lieu of flowers, the family asks that the county be given the health department the Commonwealth never built it — before Washington has to send a second detective to find out why the first one was sent alone.

Continued on Page H14

Russia's plague watchdog downgrades mystery death from 'outbreak' to 'pneumonia' in four days

On October 3rd the wire said a scientist died at an anti-plague institute in Siberia, nearly two hundred people went into isolation, and the word on the page was outbreak. Black plague. The kind of word that gets a region quarantined and a headline written in capital letters.

Four days later the word is pneumonia. That's it. That's the whole update. Russia's consumer watchdog, the agency that speaks for the government on things like this, says an employee of the Irkutsk institute "contracted pneumonia." No outbreak. No isolation count. No institute name beyond the one everybody already knew. One worker, one diagnosis, filed and closed, like the first report never happened.

It didn't stay closed. The WHO isn't asking because it doubts the word pneumonia. It's asking because the watchdog answered a question nobody asked and skipped the one everybody did: how many, and is this the only one.

The United States asked too. The State Department formally sought information from Russia about a possible plague death — not a comment, not a statement, a formal request, the kind a government files when the informal channels already came back empty. Two governments, one from Geneva and one from Washington, now hold a request each, and as of today neither has an answer sitting in their hands.

That's the shape of it: a lab, a death, a word that shrank from outbreak to pneumonia in the time it takes to draft a press release, and two institutions now on record asking the question the shrinking was built to avoid. Nobody here has to invent a cover-up. The WHO noticed. The State Department noticed. The receipts are the institute's own silence, dated, and still uncollected.

Continued on Page H2

Hospitals that skip price disclosure half the time profit off a poverty subsidy in wealthy suburbs.

The filing's own headline does the reconciling for us: "Robin Hood in reverse."

A month earlier, the same publication had already run the ledger on what nonprofit hospitals do with the slack. The September 1 filing put a number on it: $14 billion, its own figure, attached to hospitals it said "hoard wealth while gouging patients." The same filing noted that Congress and the administration were taking what it called serious steps toward transparency and accountability for those hospitals. Steps were, by its account, underway.

Nine days later the first readout on those steps arrived. The Patient Rights Advocate group's eighth report, out September 10, put hospital compliance with the federal price-transparency rule at a record high. The record high was 49.4 percent. Roughly half the industry posts its prices where a patient could find them before a bill arrives; roughly half does not. Calling that a record tells you what the previous seven reports found.

Lay the three filings end to end and the gap gets an address. The sector drawing margin off a poverty subsidy in zip codes that never needed one is the same sector running a coin-flip rate of compliance with the rule meant to let a patient see a price coming. None of the three filings draws a line connecting the two facts, and none rules it out. How many 340B dollars actually reached a patient who could not pay is a number none of September's or October's filings supply, which is its own kind of finding.

The program was named for the patient at the bottom. Run the receipts end to end and the money clears somewhere else: a hospital system with a coin-flip compliance rate and a $14 billion figure attached to its sector, sitting in a zip code that was never the ask. Congress wrote the eligibility rule. It did not write the audit. That is the gap, hon, and it does not close by itself.

Continued on Page H4

The ninety dollars Treasury mailed this month is installment one of the promised five thousand, and this podium will not be putting a date or a figure on installment two.

Let me start with the number in the news. The Treasury began mailing checks this month and the checks are ninety dollars. In Dallas the president said five thousand, and that Sunday he told reporters it would "happen 100 percent" if Republicans hold Congress, which is a conditional, and November has not occurred. On the tenth, in a recorded message, he alleged the prior administration had been "massively" overcharging people on the federal exchange and pledged five hundred dollar rebates to nearly a million of them. So you have five thousand, five hundred, ninety. That is a schedule. The ninety is the first installment. It is installment one. I am not going to put a date on installment two from this podium — or a figure, the figure is Treasury's — look, when Treasury has the second one, Treasury will have it, and I would not want to characterize a second one I have not been given. Did I say installment? I would characterize it as a check. A check that went out.

On mechanics. The Treasury secretary told the House Financial Services Committee on the fifteenth that the department is examining whether it can issue the money without authorization from Congress, and examining is not doing. The critics here are our own house: Senator Collins of Maine called the proposal "extraordinarily costly" and said that from the few details available, it seems the dividend would carry no income cap. Senator Marshall of Kansas, asked at the state fair debate about a $1.2 trillion price tag, shifted. Representative Lawler of New York asked how you pay for it. Representative Flood of Nebraska said the priority needs to be the military. National Review called it reckless. Guy Benson called it a "disastrous idea." The vote the checks require sits with a senator who has said they will not fund them. That is a party conducting a debate in the open, and the ninety dollars went out during it.

Third, energy. The special envoy and the president's son-in-law flew to Moscow on September 4 and then to Kyiv; by the sixth the Kyiv leg was "encouraging," by the seventh there was "substantive progress" and a three-day pause both sides had agreed to; on the ninth the president took a call with Mr. Putin and pronounced it great. At some point in that effort, by the reporting, Mr. Putin raised with the two of them a sale of Russian energy assets — the assets Ukraine agreed not to hit. You could stand up a second delegation to hear an energy proposal. You could open an office for it. The two of them were in the room, the room was paid for, and I would call that efficiency. And I would note the word used is sale, which is a commercial term, and commerce is not — commerce is ordinary.

On the advertising. There is a campaign praising the president's presidency, it was financed out of the Department of Homeland Security, and it ran at the president's direction. That department's appropriation is border security. The ads concern the presidency. The presidency sits inside the country, and the border is the edge of the country, so the country is the thing inside the border, so an advertisement about the man inside the border is in a broad sense a border — I hear it. I hear what that sounded like. Strike it. The department has latitude, the material is informational, and the public benefits from knowing who is running the government they live inside of.

Which brings me to the comparison you intend to run. Ninety dollars to a senior this month, against the president's nine largest oil and gas holdings, which CNBC found had risen between $1.5 million and $4.4 million since the war with Iran; against 750,000 people the administration announced it is removing from Affordable Care Act coverage as "fraudulently" enrolled, a claim health policy experts met with skepticism; against an independent analyst's September 3 tally of as many as 10 million who have lost coverage under this president. Four ledgers. They do not touch. I have been shown nothing that wires them together, and the wiring is not something I will do from here. Ninety against four point four million is a unit problem. One is a check. One is a holding, and a holding is not income until you sell it. I will take the rest of this Monday. I will be here Monday.

Continued on Page H2

Woman dies waiting for the abortion Sharon Stone joked you could get from a vending machine.

Sharon Stone went on Michelle Obama's podcast and said she had a secret abortion at eighteen. In the same conversation she made the obvious joke: if men got pregnant, you could get an abortion from a vending machine. The line works because a vending machine is the least dignified way to get anything — and because, for Stone, that is also the fastest, easiest way to imagine getting one.

Tierra Walker was thirty-seven, four months pregnant by one account and twenty weeks by another, when she began having seizures, blood clots, and a hypertensive crisis. She asked, more than once, for an abortion. Doctors in Texas said no. In 2024 she died of preeclampsia. On September 16, her family sued Attorney General Ken Paxton's office and the doctors who turned her away.

The vending machine joke isn't needed to find the gap between those two stories; the lawsuit draws it in plain language. On one side, a comedian imagining ease so total it fits in a hallway snack rack next to the candy — a riff this paper is adding, not Stone's own words, because the ease she's joking about is the whole point.

That is how Texas's abortion ban works under Paxton's enforcement: doctors facing a patient in a hypertensive crisis decided the legal risk outweighed the medical one. The lawsuit doesn't allege confusion.

Stone's joke measures the distance in one direction — a known actress revealing a secret abortion and still reaching for a vending machine as the shorthand for access a man would get automatically. Walker's case measures it in the other. One is a riff about an imagined system. The other is a death certificate and a docket number, filed September 16, in the same state that is supposed to answer for both.

Continued on Page H2

Washington Examiner reports medical groups built national abortion access from laws already on the books.

Thirteen states now hold total or near-total abortion bans, the receipts call it a monumental statutory win for the side that spent decades building it. The chief looks at the parts list left behind by the court's ruling and assigns the job: find what Dobbs did not touch, and build with it.

On September 14, Massachusetts enacted a law legalizing abortion through birth, one state settling the question only inside its own line. The approval they are suing over was still in force the day they filed it.

Four days after that, on September 28, a Nevada abortion rights group opened a $1 million ad campaign for a ballot measure writing abortion protection into the state constitution, stacking a second layer onto the 24-week legal window Nevada voters had already set in 2024, 64 percent in favor. The planner studies the assembly taking shape: a federal drug approval, a telehealth line, a ballot campaign — none of it invented this year, all of it already on the books before the bans were.

Eighteen days after Massachusetts acted, on October 2, the Washington Examiner published its own accounting: across the thirteen-state ban landscape, medical groups have assembled interstate shield laws, the standing FDA approval of mifepristone, and telehealth prescribing into a workaround that functions, right now, as abortion access inside states that banned it. The tinkerer built the mechanism from exactly these parts, nothing filed with any legislature, just authority that already existed, wired together.

The muscle goes first, and the job is simple: the bans were built to stand alone, and they do not reach a drug approval issued in Washington, a prescription written across a state line, or a shield law passed somewhere that never banned anything. The pilot's job is simpler still — get the prescription to the patient on the other side of that line. The FDA has not withdrawn its approval of mifepristone. One group has asked it to. The approval remains dated, filed, standing, doing the same work it was approved to do before the first ban took effect.

Continued on Page H2

Health secretary calls AI better informed than doctors at summit doctors weren't invited to fund

The health secretary of the United States stood before the Make America Healthy Again summit this week and told the room that artificial intelligence is "better informed" than doctors. The room had opinions of its own to sell. The conference was sponsored by corporations, including AI companies and others with business pending before the same government the secretary runs. Vice President JD Vance also addressed the summit, where officials touted AI's ability to double-check the health experts Americans already see. Nobody in the room asked who double-checks the summit's sponsors.

The reconciliation starts with the invoice. A conference funded by AI companies hears from the health secretary that AI knows more than the people currently licensed to practice medicine. That is not a coincidence requiring investigation; it is a business model requiring a receipt, and the receipt exists. Run the filing against the table: the secretary who praised AI's diagnostic edge has, per disclosures reported last week, drawn four million dollars in book advances from a publisher that also monetized his MAHA platform. The same disclosure lists $210,000 in consulting fees paid to Cheryl Hines, the secretary's wife, by one of the MAHA-affiliated groups now capitalizing on his agenda. The column the four million lands in is his own. The column the $210,000 lands in is his household's.

None of this requires the secretary to be wrong about any given AI tool. It requires only noting that the man selling the platform is also the man judging the platform, and that the summit paying to hear him say so is stocked with vendors who benefit either way. A doctor's opinion is bound by a license board, a malpractice bar, and a patient in the room who can sue. An AI company's opinion, delivered through a cabinet secretary at a sponsor-funded summit, is bound by none of those, and comes with a book deal attached.

There is a second ledger worth checking, and it belongs to the party, not the man. Reporting from late August found Kennedy's own MAHA political organization had barely moved the needle for Republican candidates three months before the midterms, even as MAGA and MAHA were formally aligned. The party is betting on a movement whose most visible spokesman is drawing four million dollars from its publishing arm and touting AI to a room full of AI companies. That is the whole arrangement, reconciled: the secretary gets the advance, the wife gets the consulting fee, the sponsors get the endorsement, and the party gets whatever midterm dividend, if any, is left over. Hon, the only party in that sentence not getting paid is the patient.

Continued on Page H2

SECRETARY OF MEASLESLAND

RFK Jr.'s department earns "Secretary of Measlesland," then delivers 900 cases to prove it.

Robert F. Kennedy Jr.'s Department of Health and Human Services has this under control, and the numbers back that up if you pick the right numbers. Start with the easy part: in August, Pennsylvania's health department confirmed the state's first two measles deaths in thirty-five years, two unvaccinated Lancaster County residents, and Secretary Debra Bogen noted the obvious, that measles had been "largely eliminated" for more than three decades. Regrettable. Isolated. A fluke of geography, not policy — that's the line, and I'm sticking to it, at least until the next paragraph.

By mid-September the isolated fluke had become four deaths, two of them infants, an eighteen-year-old dead on a Tuesday and a forty-year-old woman dead the weekend before that — which the wire noted made 2026 a year with more measles deaths than any year since 1992. That's still fine. That's — Governor Josh Shapiro named Kennedy directly as the reason four Pennsylvanians are dead of a disease with a vaccine older than the outbreak, and I'd call that political theater except I can't, because he used the Secretary's actual name for the Secretary's actual department, which tracks actual outbreaks, and four people are actually dead. So. The department's handling of this is — the department is handling this.

By the twenty-third, Dr. Paul Offit was calling Kennedy's agency the "Secretary of Measlesland," a phrase that sticks because it's accurate: 2026 is now the deadliest year for measles in the country since the disease was declared eliminated in 2000. Twenty-six years of elimination, undone on this Secretary's watch, and I was going to say "undone despite this Secretary's efforts" but the sentence doesn't want to go there.

On Monday the state's dashboard hit 903 cases, up more than a hundred in a single week and up from roughly four hundred a month before that. The department's response to nine hundred is the same as its response to four hundred and the same as its response to four dead: a dashboard, updated. Not a policy. A dashboard. I was told to tell you HHS has this contained. It does not have this contained.

The count keeps climbing regardless of what either of us says about it.

Continued on Page H2

Pharma got its secret deal in weeks. The insulin cap is still waiting for a floor vote.

On September 2nd, the President stood in the Oval Office and did the math out loud: Medicare for All, he said, would cost "the entire budget of the whole country." No filing on record supports that number.

On September 20th, the paperwork behind that arrangement became public. Public Citizen filed a records request and got back the deals themselves. The filing does not read like the pitch. It reads like a contract with perks for the sellers: drugmakers may raise prices overseas to offset what they give up here, and the savings promised to American patients are narrower than what was announced.

On September 24th, Senator Sanders asked the President's nominee to run the FDA whether the President's claim about having the cheapest drugs in the world was true. The record carries the question. It does not carry an answer for me to reconcile, and I don't run figures I can't check, so I leave that one exactly where the transcript leaves it: open.

This week the same file gets a new page. CMS put out a Medicare drug-pricing proposal tied to the 2022 pricing law, pitched, like the deals before it, as relief. Lawmakers in both parties read the filing differently. They say the policy could make it harder for patients to get newer cancer treatments, by discouraging the research that makes new treatments in the first place. That is not one party's talking point against the other's. It is both parties reading the same document and landing in the same place.

In the same building, on the same calendar, Senator Shaheen is asking Senate leadership for something smaller than any of this: a floor vote on a bipartisan bill that caps what a private insurance customer pays for insulin. It does not require a secret negotiation with a drug company. It does not require a nominee to answer a question under oath. It requires a vote, and it has been requested before the Senate leaves town for the midterm recess.

Run the filing against the table, hon. The other has been sitting in a drawer, fully written, waiting on a vote nobody will schedule. That is not a coincidence of paperwork. That is what a priority looks like when you can see its receipts.

Continued on Page H2

Fox News announces Troy Jackson breaks silence and stays silent, same day, same vandalism.

The ledger for the Maine Senate race carries five entries now, and only one of them cost anyone anything.

Entry one, filed September 11: the Senate Leadership Fund ran an ad against Troy Jackson for raising taxes during his years in the Maine Senate. That line closed itself. Taxes, dated, nothing owed back.

Entry two, September 22: ProPublica reported what it called a pay-to-play arrangement running through Susan Collins's office. Collins's aide called the same report "categorically false." Both statements are on the record. Neither has been reconciled against the other, because no third document in the file does the reconciling.

Entry three, September 24, two days later: a poll put Collins ahead by three points. The corruption report had been public the whole time. The lead held anyway.

Entry four opens the same week, no sharper date attached than that, and it is the one that finally moved something other than a number. Collins's Biddeford office was spray-painted with a vulgar message. Collins said she will not be "intimidated." Both wire accounts agree on that much.

What they do not agree on is Jackson. Fox News filed two versions of the same event, both dated September 28. One headline says the Democratic nominee "breaks silence" on the vandalism. The other, filed the same day by the same outlet, says he "stayed silent." The body copy under each is nearly identical. The wire disagrees with itself about whether the challenger in this race has spoken, on the same day, in the same publication.

That is the entry as filed: not a timeline of when Jackson spoke, because the receipts carry none, but a filing that contradicts its own header. Collins gets a vandalism story that lets her sound composed. Jackson gets two competing headlines, and correcting either one is not his to do.

Run the columns against each other and the gap is not between Collins and Jackson. It is between what one outlet published about Jackson twice in a single day and what it actually knew when it did. The corruption report stands answered only by the aide who denied it. The poll has not moved. Navatek's contracts have not moved either. The only entry in this ledger with a fixed number attached is the one dated September 24, and it says three.

Continued on Page H3

Oxford's mayor names the culprit a week before toxicology can.

Two University of Mississippi students died, and before toxicology could say why, Oxford's mayor stood in front of cameras and said why. Robyn Tannehill called kratom "rolling the dice on death." The line landed the same day the state's commissioner of public safety told reporters that toxicology results — the actual determination of what killed these two students — were expected to be completed as early as next week.

That order matters. The commissioner says confirmed toxicology results could trigger a state law aimed at cracking down on fentanyl dealers. A mayor's press conference doesn't wait on a lab. So while the toxicology work continues on its own timeline, the public already has an explanation, offered a week ahead of the evidence that would test it.

Fraternity hazing survivor Andrew Lohse raised a second warning the same week, tied to the same story: a "code of silence" inside Greek life, one he says connects the Ole Miss deaths to an alleged cocaine ring at Penn State.

Put the two warnings side by side and the shape gets clear. One is loud, timed to the news cycle, aimed at a substance the toxicology report hasn't confirmed. The other says the institution surrounding these two students has a track record of making sure whatever that report finds never gets read past the headline. The mayor answered the question she's allowed to ask in public. Whether the fraternity system answers the harder one is the actual test, and so far nobody's called a press conference for that one.

Either way, the mayor already told two grieving families what killed their kids. The lab's job now is to catch up.

Continued on Page H2

Kennedy Pledged To Divest From Vaccine Suit, Senate Now Asks If He Kept A Cut

He pledged to get out of a lawsuit against a vaccine manufacturer, the same lawsuit he was still a party to during his confirmation process last year. It means the money stops running through him. That pledge is the cleanest sentence in the file.

The senators asked DOJ to determine whether that statement was true. The request went in. As of today, no resolution has followed it.

On September 17, Kennedy returned to the anti-vaccine group he used to chair and delivered the keynote, reviving concerns about vaccine injuries from the stage. That appearance answers neither the Samoa question nor the divestiture pledge. It does put the secretary of Health and Human Services back in front of the exact subject matter the ethics agreement was written to wall him off from, eight days before the next filing.

That filing arrived September 25. A group of Senate Democrats say Kennedy may have arranged to keep collecting money from a settlement with the vaccine manufacturer he pledged to divest from, and that the arrangement was not disclosed. Lay the two documents side by side: one says the money stops, the other raises the question of whether it kept moving. The size of that gap is not written down anywhere in either filing. That is not an oversight. Divestiture pledges do not come itemized; they come as a promise, and the follow-up paperwork confirming a promise was kept is the one document this file does not contain.

Reconcile it the plain way, hon: a pledge to stop collecting, a report that he may not have stopped, and between them the confirmation that would settle it either way, still missing from the record. The Samoa answer has sat at DOJ since August 28 without a finding. The keynote happened regardless. The pledge remains the only sentence in this file that both sides agree Kennedy signed, and it is the sentence the September 25 filing exists to ask about.

Continued on Page H2

The health archive — every headline the section has run